PodcastIntel
Sign in Get Started Free
Science, Spoken
Science, Spoken

Wegovy Slashes the Risk of Heart Attack and Stroke in a Landmark Trial

Nov 14, 2023 · 9m
✨ AI Summary
  • Wegovy significantly reduces heart attack and stroke risk.
  • Semaglutide, used for weight loss, shows cardiovascular benefits.
  • Landmark trial suggests broader health applications for the drug.

More from Science, Spoken

View all episodes →

Get AI Summaries for Every New Episode

Subscribe to Science, Spoken and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →